🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Status
Unknown
Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Start Date
2019-02-15
Trial ID
NCT03487016
Treatments Being Tested
The purpose of this first-in-human study is to evaluate the safety, tolerab...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2025-07-31
Trial ID
NCT07094113
Treatments Being Tested
The goal of this Phase I clinical trial is to evaluate how the imaging drug...
Status
Recruiting
Location
Excel Diagnostics & Nuclear Oncology Center
Start Date
2026-08-15
Trial ID
NCT07733674
Treatments Being Tested
This study will test the safety of a drug called PF-08046052/SGN-EGFRd2 in ...
Status
Terminated
Location
Ronald Reagan UCLA Medical Center
Start Date
2023-11-14
Trial ID
NCT05983133
Treatments Being Tested
The purpose of this study is to determine the proportion of pancreatic pati...
Status
Terminated
Location
Stephenson Cancer Center
Start Date
2022-12-07
Trial ID
NCT05275075
Treatments Being Tested
The goal of this observational study is to learn about early recurrence aft...
Status
Enrolling By Invitation
Location
University of Padova
Start Date
2025-10-23
Trial ID
NCT07241676
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) carries one of the worst prognoses ...
Status
Not Yet Recruiting
Location
Linkou Chang Gung Memorial Hospital
Start Date
2026-09-01
Trial ID
NCT07597252
This study is the study of the combination of PEGPH20 and Pembrolizumab (MK...
Status
Unknown
Location
Banner Health - MD Anderson Cancer Center
Start Date
2019-05-01
Trial ID
NCT03634332
Treatments Being Tested
This study will check how well a new medicine, Risvutatug rezetecan, (Ris-R...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-06-11
Trial ID
NCT06885034
Treatments Being Tested
Pancreatic cancer exhibits significant heterogeneity, which poses a major c...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07592819
Treatments Being Tested